Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yukimichi Imai"'
Autor:
Yu Nakamura, Mikiko Usui, Takashi Nishikawa, Masashi Takita, Masahiro Shigeta, Yukimichi Imai, Katsuya Urakami, Hiroshi Kita, Akira Homma
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 2, Iss 1, Pp 271-277 (2012)
Background/Aims: CIBIC plus-J is the Japanese language version equivalent to CIBIC plus. Variability of CIBIC plus-J arises among raters in accordance with their experience and their memories of patients’ conditions at baseline. Therefore, in a mul
Externí odkaz:
https://doaj.org/article/a7909c3cb8d447f186758a04acb6522b
Autor:
Yu Nakamura, Yukimichi Imai, Masahiro Shigeta, Ana Graf, Toru Shirahase, Hyosung Kim, Akifumi Fujii, Joji Mori, Akira Homma
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 1, Iss 1, Pp 163-179 (2011)
Background: As of 2010, the rivastigmine patch was licensed for the treatment of Alzheimer’s disease (AD) in 64 countries. Methods: This 24-week, multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy, safety and tol
Externí odkaz:
https://doaj.org/article/752c75f6bfca4637bfe80e509795d760
Autor:
Akira Homma, Masahiro Shigeta, Katsuya Urakami, Yukimichi Imai, Mikiko Usui, Masashi Takita, Hiroshi Kita, Takashi Nishikawa, Yu Nakamura
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 2, Iss 1, Pp 271-277 (2012)
Dementia and Geriatric Cognitive Disorders EXTRA
Dementia and Geriatric Cognitive Disorders EXTRA
Background/Aims: CIBIC plus-J is the Japanese language version equivalent to CIBIC plus. Variability of CIBIC plus-J arises among raters in accordance with their experience and their memories of patients’ conditions at baseline. Therefore, in a mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f906c4d4e27115674c9c90c99c5803
http://www.karger.com/Article/FullText/339953
http://www.karger.com/Article/FullText/339953
Autor:
Masahiro Shigeta, Joji Mori, Yu Nakamura, Yukimichi Imai, Ana Graf, Toru Shirahase, Akira Homma, Akifumi Fujii, Hyosung Kim
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 1, Iss 1, Pp 163-179 (2011)
Dementia and Geriatric Cognitive Disorders EXTRA
Dementia and Geriatric Cognitive Disorders EXTRA
Background: As of 2010, the rivastigmine patch was licensed for the treatment of Alzheimer’s disease (AD) in 64 countries. Methods: This 24-week, multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy, safety and tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b164f772d91417fa80675bc23a173995
https://doi.org/10.1159/000328929
https://doi.org/10.1159/000328929
Autor:
Takao Takase, Takashi Asada, Masahiro Shigeta, Akira Homma, Toshihiko Iwamoto, Toshio Ohbayashi, Itaru Arimoto, Hisao Tago, Hiroshi Koma, Masashi Takita, Yukimichi Imai
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 27:232-239
Background/Aims: A 6-month, randomized, double-blind, placebo-controlled study was extended to evaluate long-term safety and efficacy of donepezil in community-dwelling Japanese patients with severe Alzheimer’s disease (AD). Methods: 189 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc1f51517e285222d837ae8ccd0fae0e
https://doi.org/10.1159/000203887
https://doi.org/10.1159/000203887
Autor:
Yukimichi Imai
Publikováno v:
Psychogeriatrics. 6:S4-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8e11715c4aad5f2fb13c603f16f6b26
https://doi.org/10.1111/j.1479-8301.2006.00124.x
https://doi.org/10.1111/j.1479-8301.2006.00124.x
Autor:
Masatoshi Takeda, Akira Homma, Fukashi Udaka, Yukimichi Imai, Kazuo Hasegawa, Masakuni Kameyama, Tsuyoshi Nishimura
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 11:299-313
This study evaluated efficacy and safety of donepezil hydrochloride (donepezil) at 5 mg/day in patients with mild to moderately severe Alzheimer’s disease for 24 weeks in a double-blind, placebo-controlled comparative trial. In this study, 268 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c1aa5d61282be32a026cdc338f80b7
https://doi.org/10.1159/000017259
https://doi.org/10.1159/000017259
Autor:
Wayne C. McCormick, Kamal Masaki, Akira Homma, Yasuyo Mimori, Hideo Sasaki, James D. Bowen, Yukimichi Imai, Susan M. McCurry, Lon R. White, Eric B. Larson, Webb Ross, Helen Petrovitch, Michiko Yamada, Amy Borenstein Graves, Madeline Murguia Rice, Nancy Zee
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. :M313-M319
Background Clinical investigators from Seattle, Honolulu, Tokyo, and Hiroshima participated in two standardization exercises in which data were collected on independent assessments. Exercises were conducted to evaluate the interobserver agreement on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::542d3a02eec63e7a79fb219194933ca1
https://doi.org/10.1093/gerona/53a.4.m313
https://doi.org/10.1093/gerona/53a.4.m313
Autor:
Masami, Hasebe, Yukimichi, Imai
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d9fb5e4afc928f30025def9eef5c955
https://pubmed.ncbi.nlm.nih.gov/22755167
https://pubmed.ncbi.nlm.nih.gov/22755167
Autor:
Hyosung Kim, Akira Homma, Akifumi Fujii, Toru Shirahase, Yukimichi Imai, Masahiro Shigeta, Yu Nakamura, Joji Mori, Ana Graf
Publikováno v:
Alzheimer's & Dementia. 7
Background: As of 2010, the rivastigmine patch was licensed for the treatment of Alzheimer’s disease (AD) in 64 countries. Methods: This 24-week, multicenter, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc9caf7ce4f5f3b8c1f174ec87756b72
https://doi.org/10.1016/j.jalz.2011.05.2257
https://doi.org/10.1016/j.jalz.2011.05.2257